Intra-operative radiographic margin assessment tool for breast-conserving surgery
保乳手术的术中放射线切缘评估工具
基本信息
- 批准号:7479492
- 负责人:
- 金额:$ 9.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:BoxingBreastBreast MicrocalcificationBreast-Conserving SurgeryCaringCharacteristicsClinicalCountryDiagnostic radiologic examinationExcisionFiberGoldHistologicHistopathologyHospitalsImageImageryLeadLeftMalignant NeoplasmsMammary Gland ParenchymaMammary NeoplasmsMastectomyMethodsNoduleNormal tissue morphologyOperating RoomsOperative Surgical ProceduresOutcomePathologyPatientsPhase I Clinical TrialsProceduresPropertyRadiation therapyRateRecurrenceResearchRiskSensitivity and SpecificitySimulateSpace PerceptionSpecimenSpecimen HandlingStandardizationStandards of Weights and MeasuresSystemTechniquesTimeTissue SampleTissuesdesigndigitalexpectationexperienceimprovedmalignant breast neoplasmpre-clinicalresearch clinical testingtooltumor
项目摘要
DESCRIPTION (provided by applicant): Breast-conserving surgery (BCS) is commonly defined as the surgical removal of a breast tumor with a safe margin of normal tissue. When supplemented with radiation therapy, BCS is generally referred to as breast-conserving therapy, or BCT. Local recurrence of breast cancer is a serious increased risk in patients undergoing BCS. For example, Atkins and colleagues have shown that the local recurrence rate following local excision was 16%, compared with 8% following mastectomy, even when supplemented with radiotherapy and chemotherapy5. Since the objective of BCS is not to leave any cancer behind in the breast, obtaining tumor-negative margins when performing BCS is the standard of care to minimize the risk of local recurrence6. Despite the attempt to achieve negative margins, primary excision for BCS yields histologically positive margins 20% to 55% of the time7. Furthermore, permanent section histopathology, the gold standard of determining margin status, is generally not available until well after the patient has left the operating room. As a result, a high percentage of patients (20 to 55% of patients with positive margins in primary excision) must return to the hospital for surgical re-excisions. Intra-operative methods of margin assessment, which are designed to provide information on margin status while the patient is still on the operating table, have so far been of limited clinical value. The long-term objective of this research is to improve the sensitivity and specificity of intra-operative margin assessment techniques for breast tissue specimens excised during BCS, and thus reduce surgical re-excision rates associated with this procedure. Phase I study objectives are: Specific Aim 1: Design and develop a surgical specimen container optimized for BCS. Specific Aim 2: Develop simulated excised breast tissue specimens with embedded simulated microcalcifications, nodules and fibers, which realistically depict both the physical and x-ray imaging characteristics of actual clinical breast tissue specimens. Specific Aim 3: Perform the pre-clinical evaluation of the specimen container against established clinical requirements of BCS utilizing simulated excised breast tissue specimens. We propose to quantify the efficacy of this tool with respect to: orthogonal x-ray imaging of specimens; providing optimal compression of specimens; and its ability to retain the three dimensional spatial orientation of the specimen from the time the specimen is excised in the operating room to the time the specimen is delivered to the Pathology Department.
描述(由申请人提供):保乳手术(BCS)通常定义为手术切除乳腺肿瘤,并保留正常组织的安全边缘。当辅以放射治疗时,BCS通常被称为保乳治疗或BCT。乳腺癌局部复发是接受BCS患者的严重风险增加。例如,阿特金斯及其同事已经表明,局部切除术后的局部复发率为16%,而乳房切除术后的局部复发率为8%,即使辅以放疗和化疗5。由于BCS的目的是不留下任何癌症在乳房中,获得肿瘤阴性边缘时,进行BCS是护理标准,以尽量减少局部复发的风险6。尽管尝试获得阴性切缘,但BCS的原发性切除产生组织学阳性切缘的概率为20%至55%。此外,永久切片组织病理学,确定边缘状态的金标准,通常在患者离开手术室后很久才可用。因此,很高比例的患者(20 - 55%的患者在初次切除时切缘阳性)必须返回医院进行再次手术切除。术中切缘评估方法旨在提供患者仍在手术台上时的切缘状态信息,迄今为止临床价值有限。本研究的长期目标是提高BCS期间切除的乳腺组织标本的术中边缘评估技术的敏感性和特异性,从而降低与该手术相关的手术再切除率。I期研究目标是:具体目标1:设计和开发针对BCS优化的手术标本容器。具体目标二:开发嵌入模拟微钙化、结节和纤维的模拟切除乳腺组织标本,真实地描绘实际临床乳腺组织标本的物理和X射线成像特征。具体目标3:根据BCS的既定临床要求,使用模拟切除的乳腺组织样本对样本容器进行临床前评价。我们建议量化该工具在以下方面的功效:标本的正交X射线成像;提供标本的最佳压缩;以及其从标本在手术室中被切除到标本被递送到病理科的时间保持标本的三维空间取向的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emre Toker其他文献
Emre Toker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emre Toker', 18)}}的其他基金
Super-resolution dual-energy dental CT based on distributed x-ray source and photon counting detector
基于分布式X射线源和光子计数探测器的超分辨率双能牙科CT
- 批准号:
10258444 - 财政年份:2021
- 资助金额:
$ 9.9万 - 项目类别:
Novel tetrahedron beam CT for point-of-care imaging in ear, nose and throat imaging
新型四面体束 CT,用于耳鼻喉成像中的护理点成像
- 批准号:
10546823 - 财政年份:2018
- 资助金额:
$ 9.9万 - 项目类别:
Novel tetrahedron beam CT for point-of-care imaging in ear, nose and throat imaging
新型四面体束 CT,用于耳鼻喉成像中的护理点成像
- 批准号:
10688182 - 财政年份:2018
- 资助金额:
$ 9.9万 - 项目类别:
Intra-operative specimen tomosynthesis for margin assessment in breast surgery
术中标本断层合成用于乳腺手术切缘评估
- 批准号:
7667559 - 财政年份:2009
- 资助金额:
$ 9.9万 - 项目类别:
Sentinel lymph node biopsy system for breast cancer
乳腺癌前哨淋巴结活检系统
- 批准号:
6550232 - 财政年份:2001
- 资助金额:
$ 9.9万 - 项目类别:
Sentinel lymph node biopsy system for breast cancer
乳腺癌前哨淋巴结活检系统
- 批准号:
6669135 - 财政年份:2001
- 资助金额:
$ 9.9万 - 项目类别:
Sentinel lymph node biopsy system for breast cancer
乳腺癌前哨淋巴结活检系统
- 批准号:
6402453 - 财政年份:2001
- 资助金额:
$ 9.9万 - 项目类别:
DIGITAL BREAST SPECIMEN RADIOGRAPHY FOR IMPROVED BIOPSY
用于改进活检的数字化乳房标本放射成像
- 批准号:
2111438 - 财政年份:1995
- 资助金额:
$ 9.9万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Research Grant
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Launchpad
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Research Grant
Enhancements to design and testing of Body Aspect's breast volume measurement software
Body Aspect 乳房体积测量软件的设计和测试得到增强
- 批准号:
10074432 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Collaborative R&D
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer
解读单细胞突变过程对三阴性乳腺癌和高级别浆液性卵巢癌的影响
- 批准号:
477662 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Operating Grants
225Ac-labeled anti-nectin-4 radioimmunoconjugate with/without immune checkpoint blockage in triple negative breast cancer.
225Ac 标记的抗 nectin-4 放射免疫缀合物,有/没有免疫检查点阻断治疗三阴性乳腺癌。
- 批准号:
488261 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Operating Grants
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
确定参与促进乳腺癌休眠逃逸的分子和环境因素。
- 批准号:
488246 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Operating Grants














{{item.name}}会员




